About
Remedee Labs, a French start-up that is part of Future4care’s accelerator program, has developed and refined the first non-invasive neuromodulation solution that revolutionizes chronic pain management. In December 2022, the company has entered in a partnership with Generali France, providing Remedee Labs with the resources to accelerate the commercialization of its solution both domestically and abroad. Additionally, the partnership enables Remedee Labs to continue to advance its neuromodulation technology and broaden its range of services.
